EuBiologics Co., Ltd.
206650.KQ
Price:
$12120
Market Cap:
$443.89B
EuBiologics Co., Ltd., a biopharmaceutical company, develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine. The company also provides customized services for mammalian cell and microbial cell derived biopharmaceuticals in accordance with the clients' project stages, including cell line development, GMP production, validation, and the regulatory support; and operates facilities that manufacture protein-based therapeutics and antibodies. It specializes in manufacturing a range of mammalian cell and microbial cell derived biopharmaceuticals, including recombinant ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-01-24
Stock Exchange
KOE
Ticker
206650.KQ
PE Ratio
[-102.16]
ROE
[32.20%]
Current Ratio
[3.60]
Dividend Yield
[0%]
Enterprise Value
[424.16B]
Dividend History
The Current Ratio as of December 2025 (TTM) for EuBiologics Co., Ltd. (206650.KQ) is 3.60
According to EuBiologics Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 3.60. This represents a change of 37.02% compared to the average of 2.62 of the last 4 quarters.
EuBiologics Co., Ltd. (206650.KQ) Historical Current Ratio (quarterly & annually)
How has 206650.KQ Current Ratio performed in the past?
The mean historical Current Ratio of EuBiologics Co., Ltd. over the last ten years is 1.77. The current 3.60 Current Ratio has changed 20.23% with respect to the historical average. Over the past ten years (40 quarters), 206650.KQ's Current Ratio was at its highest in in the September 2025 quarter at 3.60. The Current Ratio was at its lowest in in the June 2021 quarter at 1.09.
Average
1.77
Median
1.82
Minimum
0.53
Maximum
3.11
EuBiologics Co., Ltd. (206650.KQ) Current Ratio by Quarter and Year
Discovering the peaks and valleys of EuBiologics Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 159.44%
Maximum Annual Current Ratio = 3.11
Minimum Annual Increase = -56.83%
Minimum Annual Current Ratio = 0.53
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 2.11 | 31.57% |
| 2023 | 1.61 | -30.34% |
| 2022 | 2.31 | -25.84% |
| 2021 | 3.11 | 53.22% |
| 2020 | 2.03 | 159.44% |
| 2019 | 0.78 | -32.82% |
| 2018 | 1.16 | -56.83% |
| 2017 | 2.70 | 100.05% |
| 2016 | 1.35 | 152.68% |
EuBiologics Co., Ltd. (206650.KQ) Average Current Ratio
How has 206650.KQ Current Ratio performed in the past?
The current Current Ratio of EuBiologics Co., Ltd. (206650.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.01
5-year avg
2.23
10-year avg
1.77
EuBiologics Co., Ltd. (206650.KQ) Current Ratio vs. Peers
How is 206650.KQ’s Current Ratio compared to its peers?
EuBiologics Co., Ltd.’s Current Ratio is greater than JW Pharmaceutical Corporation (1.51), greater than JW Pharmaceutical Corporation (1.51), greater than JW Pharmaceutical Corporation (1.51), less than Humedix Co., Ltd. (9.22), greater than HLB Pharmaceutical Co., Ltd (1.95), greater than Yungjin Pharm. Co., Ltd. (1.22), greater than Huons Global Co., Ltd. (1.96), greater than Dong-A ST Co., Ltd. (1.53), greater than FutureChem Co.,Ltd (2.47), greater than Dentium Co. Ltd. (1.62),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.51 | $648.13B | |
| 1.51 | $561.37B | |
| 1.51 | $517.78B | |
| 9.22 | $428.43B | |
| 1.95 | $476.56B | |
| 1.22 | $358.83B | |
| 1.96 | $621.18B | |
| 1.53 | $510.39B | |
| 2.47 | $682.80B | |
| 1.62 | $388.51B |
Build a custom stock screener for EuBiologics Co., Ltd. (206650.KQ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EuBiologics Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
EuBiologics Co., Ltd. (206650.KQ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like EuBiologics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is EuBiologics Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for EuBiologics Co., Ltd. (206650.KQ)?
What is the highest Current Ratio for EuBiologics Co., Ltd. (206650.KQ)?
What is the 3-year average Current Ratio for EuBiologics Co., Ltd. (206650.KQ)?
What is the 5-year average Current Ratio for EuBiologics Co., Ltd. (206650.KQ)?
How does the current Current Ratio for EuBiologics Co., Ltd. (206650.KQ) compare to its historical average?